Industry Share, Growth Rate, Regional Analysis Report by 2027 – Shanghaiist
The latest research report from the IMARC group, titled “Companion Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
The global companion animal health market reached a value of US$21.18 billion in 2021. Looking ahead, IMARC Group expects the market to reach a value of $36.19 billion by 2027presenting a CAGR of 8.80% over the period 2022-2027. Pet health represents the regular monitoring of animal health to detect diseases and other conditions that can be life-threatening if left untreated. These are the development of therapeutic vaccines, anti-neoplastic drugs, monoclonal antibody therapies, genomic tests, digital technologies, etc. Animals, such as dogs, cats, equines, etc., are taken for health diagnostics. Pet health finds many applications in veterinary hospitals, clinics, in-house testing, point-of-care testing, and more.
Get a free sample copy of the report at – https://www.imarcgroup.com/companion-animal-health-market/requestsample
Important Attribute and Report Highlights:
- Detailed Global Market Share Analysis
- Market segmentation by animal type, product and end user.
- Historical, current and projected market size in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Companion Animal Health Market
- Strategies of key players and product offerings
Aging of animals leads to increased risks of obesity, osteoarthritis, tumors, cardiovascular disease (CVD), diabetes mellitus, liver disease, kidney disease, etc., which mainly drives the animal health market pets. Additionally, the growing awareness of the One Health (OH) initiative, which recognizes that public health is linked to animal health and is supported by the World Health Organization (WHO) and American Veterinary Medical Association (AVMA), further increases market growth. Apart from this, the growing use of animal-assisted therapy in various fields of human health and the growing population of traditional companion animals including dogs and cats are also driving the global market. Additionally, the growing number of pet parents in the counties who are aware of the general health and well-being of pets is acting as another significant growth driver. Additionally, the increasing prevalence of zoonotic diseases across the world is expected to bolster the companion animal health market in the coming years.
Key Players Included in the Global Companion Animal Health Market Research Report:
- Agrolabo SpA
- Boehringer Ingelheim
- Ceva Animal Health
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Incorporated
- IDEXX Laboratories Inc.
- Indian Immunologicals Limited (National Dairy Development Council)
- Merck & Co. Inc.
- Norbrook Laboratories
- Vetoquinol SA
- Virbac and Zoetis Inc.
Overview of the impact of COVID-19:
We regularly monitor the direct effect of COVID-19[feminine] in the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
Key Market Segmentation:
Breakdown by type of animal:
Breakdown by product:
- Food additives
Breakdown by end user:
- Point-of-Care Screening/In-House Testing
- Hospitals and veterinary clinics
Breakdown by region:
- North America (USA, Canada)
- Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Table of Contents of Companion Animal Health Market Research Report:
- Scope and methodology
- Global Pet Health Market
- SWOT analysis
- Value chain analysis
- Price analysis
- Competitive landscape
Browse other related reports:
Who we are:
The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 United States
Email: [email protected]
Such. :(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800